The research group included patients
with autoimmune hepatitis who were treated at Hannover Medical School between 2000 and 2014.
«Our study examines the clinical and genetic features of remission, relapse and liver transplant - free survival in
autoimmune hepatitis patients.»
Primary sclerosing cholangitis (PSC) is considered to be another form
of autoimmune hepatitis of the liver, although the underlying mechanism has not been definitively identified.
The team found that those patients with cases complicated
by autoimmune hepatitis or cholestatic liver disease had the greatest survival benefit compared with deceased donors when they received a living donor transplant performed at an experienced center.
The initial tests for these rare conditions — Wilson disease, hemochromatosis,
autoimmune hepatitis primary biliary cholangitis — set a low bar.
There are many disorders which may affect the body, some of which
include autoimmune hepatitis, endometriosis, fibromyalgia, juvenile rheumatoid arthritis, rheumatic fever, vitiligo, and sperm and testicular autoimmunity.
Patients diagnosed
with autoimmune hepatitis in childhood had a greater relapse risk, higher risk of needing a liver transplant, and a reduced life expectancy.
Dr. Vogel concludes, «
Autoimmune hepatitis patients diagnosed in childhood, those that present with cirrhosis at the time of initial diagnosis or who have SLA / LP antibodies have poor clinical outcomes,; these patients are in need for close surveillance.
New research reports that cirrhosis at first diagnosis and antibodies for the soluble liver antigen / liver pancreas antigen (SLA / LP) are major risk factors for poor short - and long - term outcome in patients with
autoimmune hepatitis.
Autoimmune hepatitis is a chronic inflammatory disease in which the immune system attacks healthy liver cells causing damage to the organ.
«While early diagnosis along with optimal medical therapy offers patients with
autoimmune hepatitis a good prognosis, the disease can be very severe in some cases,» explains lead author Dr. Arndt Vogel from Hannover Medical School in Hannover, Germany.
People with IBD are also at an increased risk for certain liver diseases, such as primary sclerosing cholangitis (found primarily in those with ulcerative colitis),
autoimmune hepatitis, and primary biliary cirrhosis.
I have several illnesses, the major ones being
autoimmune hepatitis, lupus, diabetes, and IBS.
Over the past two decades, Dr. Berkson has used ALA to treat a variety of liver disorders, including NAFLD, hepatitis B and C,
autoimmune hepatitis and primary biliary cirrhosis.
I am a 48 year old female, suffering since 2007 from Lupus,
autoimmune hepatitis, and now RA.
There have also been a few studies focused on the medication's effects relating to autoimmune diseases, including thyroiditis, as well as diabetes and
autoimmune hepatitis, in genetically - susceptible individuals.